Table 1.
n=497 (%)* | |
---|---|
Age at diagnosis | |
Mean | 65.3 (range 33–88) |
31–40 | 4 (1%) |
41–50 | 31 (6%) |
51–60 | 117 (24%) |
61–70 | 166 (33%) |
71–80 | 136 (27%) |
81–90 | 24 (5%) |
Unknown | 19 (4%) |
Gender | |
Male | 234 (47%) |
Female | 263 (53%) |
Race | |
White | 367 (74%) |
African-American | 46 (9%) |
Hispanic | 7 (1%) |
Asian | 8 (2%) |
American Indian | 1 (0%) |
Unknown | 68 (14%) |
Smoking status | |
Former | 292 (59%) |
Current | 119 (24%) |
Never | 72 (14%) |
Unknown | 14 (3%) |
Stage** | |
I | 264 (53%) |
II | 123 (25%) |
III | 83 (17%) |
IV | 26 (5%) |
Unknown | 1 (<1%) |
Prior malignancy | |
No | 407 (82%) |
Yes | 90 (18%) |
Data were available for 497 of 555 individuals for whom sequence data were analyzed.
Lung cancer stage was determined based on American Joint Commission on Cancer (AJCC) criteria, 5th to 7th editions (1991–2013).